Accium Early Drug Development Partnerships

The use of AMS in early drug development research continues to grow and new applications are continually being developed.  Accium has the expertise, experience and operations to perform all aspects of AMS analysis. 

To assist our clients in the development and execution of clinical trials Accium BioSciences has formed partnerships with the leading clinical CROs, radiolabel synthesis providers, pharmacokinetics modelers and regulatory compliance consultants to offer a turnkey operation.

Our clients have the flexibility to contract a clinical study through Accium or through our partners. 

Quintiles Transnational

Quintiles Phase I services brings together an unequaled breadth and depth of experience and services. We offer unrivaled expertise for safe, innovative, early-phase human drug development to Good Clinical Practice and Good Laboratory Practice standards.

All Quintiles Phase I units combine superb healthcare and analytical facilities with the complex amenities needed to attract, house and motivate volunteers. The specialized staff at each site includes physicians, pharmaceutical scientists, nurses, investigators, analysts and pharmacokineticists with experience in numerous therapeutic areas. Each unit has established its own reputation for excellence and its own loyal client base.

PRA International                                                                              

PRA is one of the world’s leading clinical development organizations with more than 2,700 employees worldwide providing reliable service delivery, program-level therapeutic expertise, easy global access to knowledge and involved senior management to our customers.

Over the past 25 years, PRA has earned the confidence of the pharmaceutical and biotechnical industries through our unique approach we call Project Assurance^®: A company-wide commitment to consistently achieve customers’ requirements everywhere in PRA.

CMIC (Japan)

The CMIC Group consists of fourteen companies, including CMIC Co., Ltd. and consolidated affiliates. The Group's businesses mainly involve support for the pharmaceutical industry. Instead of making drugs, we offer comprehensive services related to drug, all the processes of a pharmaceuticals company from research and development to manufacture and sale. Leveraging our experience and expertise as a pioneer CRO, our business has expanded to create added value in such fields as drugs, medical devices, specific functional foods, and so on. Moreover, we are tackling the service which is useful to "the medical treatment for a patient" also in the field of medical treatment and healthcare, strengthening customer service as "PVC (Pharmaceutical Value Creator)" which contributes for value maximization of a pharmaceuticals company.

The main service areas include: Monitoring, Data management, CRC business, Pharmaceutical affairs consulting and Pre-clinical work.

Charles River Laboratories Clinical Services

Effective early clinical evaluation of new therapeutics is essential for progressing your compound to market approval and requires careful study design, volunteer selection, and clinical oversight. With Charles River’s extensive expertise you can be sure of safe, accurate, and timely implementation of your clinical trials.   

Clinical pharmacology studies represent the first introduction of a new drug into human subjects. Given the risks associated with these trials, you need a partner that can effectively customize individual studies and advance your product to the next clinical phase without compromising patient safety. With our experience in both routine and procedurally intensive studies, Charles River has the ability to conduct well-designed clinical safety programs. In addition, we offer expert oversight to correlate and verify preclinical findings. 

Our clinicians can assist in determining a drug’s pharmacologic action, metabolism, and side effects, as well as its overall clinical safety, through a wide range of clinical study types. As clinical trials begin, further in vitro and in vivo nonclinical studies performed within our global network of facilities provide additional information to support the continuation of clinical trials. Charles River is world-renowned for its developmental and reproductive toxicology and other specialty toxicology areas, such as inhalation, infusion, and photobiology, all of which are supported by the largest collective group of pathologists in the industry.

Analytical Bio-Chemistry Laboratories (ABC)

Analytical Bio-Chemistry Laboratories' mission is to be a premier provider of development services to the pharmaceutical and chemical industries. Analytical Bio-Chemistry Laboratories enables clients to realize higher profits and reduce development risk while accelerating time to market.

Radiolabeled (¹⁴C) GMP API for early clinical trials - Projects are conducted in conformance with the company's NRC approved Radiation Safety Program and are overseen by an experienced Radiation Safety Officer approved by the NRC. ABC has had an NRC license since the early 1970s and the most recent inspection was October 2002. The inspection was routine and there were no reportable findings.